Due to the evident decline in the insulinotropic impact of GIP on individuals with T2DM (potentially attributed to the desensitization of the GIP system) (Vilsbøll et al., 2003), the focus of GIP research has shifted from glucose homeostasis to other areas, such as bone metabolism and other diseases. Here, GIP is linked to type 2 diabetes mellitus.